I have known Marc Tessier-Levigne to be a brilliant scientist, generous colleague, and insightful collaborator. He has tirelessly sought to advance the frontiers of knowledge and help people in need. I look forward to his continuing contributions to science and beyond.
Doug Cole retweeted
Flagship's Doug Cole and Chris Austin call on biotech to turn its imagination, creativity & resources to understanding the underlying causes of common illnesses. Read why: bit.ly/3qhX994 @DougCole2 #JPM22 #JPM2022
Doug Cole retweeted
The better we understand a disease, the earlier we can detect, delay, or derail it. My colleagues Doug Cole and Chris Austin explain how biotech is poised to pioneer the systematic development of effective treatments for common illness. #JPM22
Flagship's Doug Cole and Chris Austin call on biotech to turn its imagination, creativity & resources to understanding the underlying causes of common illnesses. Read why: bit.ly/3qhX994 @DougCole2 #JPM22 #JPM2022
So proud to be a part of @FlagshipPioneer for its #ChangeTheWorld designation by @FortuneMagazine today. The potential to harness the power of the Biological Century to help people and the planet is boundless. Congratulations, Flagship colleagues!
Flagship Pioneering congratulates Cigall Kadoch, Ph.D., our scientific Co-Founder at Foghorn Therapeutics foghorntx.com/, for her selection as an Investigator by the Howard Hughes Medical Institute hhmi.org/news/hhmi-invests-3…. Well-deserved, Cigall!
We are thrilled to welcome Brooke Story to the Sigilon Therapeutics (NASDAQ: SGTX) Board of Directors! ir.sigilon.com/news-releases…
Flagship congratulates Receptos for writing the first chapter of the ozanimod story and understanding S1P’s potential beyond MS. Proud to have backed Receptos from its founding. endpts.com/bristol-myers-get…
Susan Hockfield, Ph.D., MIT President Emerita, Joins Repertoire Immune Medicines Board of Directors • Repertoire Immune Medicines repertoire.com/about/press-r…
Doug Cole retweeted
Former @ncats_nih_gov director Chris Austin gets a warm welcome as the newest @FlagshipPioneer CEO-partner.
We at @FlagshipPioneer were so inspired by @NIHDirector's farewell song to our newest CEO-partner Chris Austin that we're responding in kind with our take on another classic Boston tune from our own @DougCole2. @ncats_nih_gov @NIH
Doug Cole retweeted
My friends at @FlagshipPioneer, including Moderna, are a little punchy. But making vaccines is tiring. This is good, Boston fun (or just sad) for those of us of a certain age. @ChristineHeenan
We at @FlagshipPioneer were so inspired by @NIHDirector's farewell song to our newest CEO-partner Chris Austin that we're responding in kind with our take on another classic Boston tune from our own @DougCole2. @ncats_nih_gov @NIH
My colleagues at @FlagshipPioneer and I are saddened by the news of Jose Baselga’s death. Jose’s leadership in all aspects of oncology—patient care, academic research, and drug development—created an enduring legacy of benefit to society. We will miss him.
The Biological Century | Flagship Pioneering flagshippioneering.com/stori…
The American Cancer Society reported that cancer mortality declined by a record 2.4% in 2018 and 31% since the 1991 peak. Credit better and earlier diagnostics and therapies and a decline in smoking. wsj.com/articles/the-good-ne…